简介：
Overview
This study presents a standardized protocol for performing lumbar intrathecal injections in neonatal, juvenile, and adult mice and rats, focusing on its application in gene therapy for rare pediatric neurological diseases. The protocol aims to guide researchers in effectively adopting this technique for preclinical gene therapy studies, which have shown safety and efficacy in ameliorating disease phenotypes in preclinical models.
Key Study Components
Area of Science
- Gene therapy
- Neurological diseases
- Preclinical models
Background
- Gene therapies are being developed for rare neurological conditions.
- Intrathecal gene delivery has been demonstrated as safe and effective.
- Gene therapies are currently in phase 1 and 2 clinical trials.
- Collaboration with patient advocacy groups is emphasized.
Purpose of Study
- To establish a reliable method for delivering gene therapy to the central nervous system.
- To guide researchers in the effective application of lumbar intrathecal injections.
- To advance promising candidates for clinical trials.
Methods Used
- A standard procedure for lumbar intrathecal injections in rodents is described.
- The technique includes careful alignment and targeting of the intervertebral space.
- The protocol outlines key sterile preparation steps, materials, and injection techniques.
- Success of the injections is assessed based on spread and expression of the gene therapy vector.
- Critical steps include proper a surgical procedure and monitoring for backflow.
Main Results
- Successful intrathecal injections led to broad distribution of gene therapy vectors within the central nervous system.
- Observations include concentrated expression in the lumbar spinal cord.
- Failures were noted in cases of intraparenchymal targeting affecting delivery success.
- Visible staining indicated successful delivery and highlighted procedural effectiveness.
Conclusions
- The study demonstrates an effective technique for gene therapy administration via lumbar intrathecal injections.
- Proper execution of this method can enhance preclinical research in gene therapy for neurological diseases.
- Insights from this technique contribute to understanding therapeutic delivery mechanisms in spinal cord-related disorders.
What are the advantages of lumbar intrathecal injections?
Lumbar intrathecal injections allow for direct delivery of therapeutics to the central nervous system, maximizing their efficacy and minimizing systemic exposure.
How is the procedure performed in juvenile mice?
The procedure involves careful handling of the mouse, disinfecting the injection site, and precise alignment with the lumbar intervertebral space for injection.
What are the outcomes measured following intrathecal injection?
Outcomes include distribution and expression of the gene therapy vector in the central nervous system, alongside visible indicators of successful delivery.
How can this technique be applied to other research?
This method can be adapted for various gene therapies targeting different neurological conditions, facilitating broader applications in disease modeling and therapeutic evaluation.
Are there limitations to this injection technique?
Challenges may include the need for specialized training to ensure proper technique and manage potential complications like backflow during injection.
What is the importance of collaboration with patient advocacy groups?
Collaboration enhances the relevance of research to patient needs, ensuring that therapeutic development is aligned with clinical priorities for rare genetic disorders.
繁體中文
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](https://www.jove.com/CDNSource/teasers/67458.jpg)
